Alkermes
ALKS
$24.38
Share price
0.95%
Change (1 day)
-20.01%
Change (1 year)
Categories
Alkermes (ALKS) - Net assets
Net assets on the balance sheet as of December 2023 : $1.20 B
According to Alkermes's latest financial reports the company has $1.20 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Alkermes - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $1.20 B | 15.23% |
| 2022-12-31 | $1.04 B | -6.19% |
| 2021-12-31 | $1.11 B | 4.27% |
| 2020-12-31 | $1.06 B | -1.7% |
| 2019-12-31 | $1.08 B | -7.33% |
| 2018-12-31 | $1.17 B | -2.62% |
| 2017-12-31 | $1.20 B | -0.55% |
| 2016-12-31 | $1.20 B | -7.97% |
| 2015-12-31 | $1.31 B | -5.91% |
| 2014-12-31 | $1.39 B | |
| 2013-03-31 | $0.95 B | 11.54% |
| 2012-03-31 | $0.85 B | 117.81% |
| 2011-03-31 | $0.39 B | -4.99% |
| 2010-03-31 | $0.41 B | -5.12% |
| 2009-03-31 | $0.43 B | 42.44% |
| 2008-03-31 | $0.30 B | 50.06% |
| 2007-03-31 | $0.20 B | 512.54% |
| 2006-03-31 | $33.21 M | 707.78% |
| 2005-03-31 | $4.11 M | -94.58% |
| 2004-03-31 | $75.92 M | -1604.76% |
| 2003-03-31 | $-5.05 M | -105.06% |
| 2002-03-31 | $99.66 M | -32.85% |
| 2001-03-31 | $0.14 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | 5,721.95% | 🇺🇸 USA |
 Novartis NVS | $39.75 B | 3,205.59% | 🇨🇭 Switzerland |
 Pfizer PFE | $89.28 B | 7,324.02% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 6,734.96% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $16.54 B | 1,275.92% | 🇺🇸 USA |
 AstraZeneca AZN | $37.50 B | 3,018.09% | 🇬🇧 UK |
 Acorda Therapeutics
ACOR | -$0.16 B | -113.13% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $8.12 B | 575.65% | 🇮🇱 Israel |